ODM-203, a novel, selective and balanced FGFR and VEGFR inhibitor with strong anti-tumor activity in FGFR- and VEGFR-dependent cancer models

被引：0
|
作者：
Holmstrom, T. [1 ]
Moilanen, A. [1 ]
Linnanen, T. [1 ]
Wohlfahrt, G. [1 ]
Karlsson, S. [1 ]
Oksala, R. [1 ]
Korjamo, T. [1 ]
Bjorkman, M. [1 ]
Samajadar, S. [2 ]
Rajagopalan, S. [2 ]
Chelur, S. [2 ]
Narayan, K. [2 ]
Ramachandra, R. [2 ]
Anthony, T. [2 ]
Ds, S. [2 ]
Ramachandra, M. [2 ]
Kallio, P. [2 ]
机构：
[1] Orion Pharma, R&D Oncol Res, Turku, Finland
[2] Aurigene Discovery Technol Ltd, Res, Bangalore, Karnataka, India
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70558-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
432
引用
收藏
页码：142 / 142
页数：1
相关论文
共 46 条
  • [21] Preliminary safety and anti-tumor activity of TYRA-300, a highly selective FGFR3 inhibitor, in participants with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301)
    Tran, B.
    Boni, A.
    Hansen, A.
    Boni, V.
    Mantia, C.
    Yu, E.
    Weickhardt, A.
    Robert, M.
    Gupta, S.
    Necchi, A.
    Morales-Barrera, R.
    Hoimes, C.
    Berlin, J.
    Iyer, G.
    Millward, M.
    Burn, T.
    Lihou, C.
    Gammon, G.
    Rosenberg, J.
    Loriot, Y.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S175 - S175
  • [22] Preclinical evaluation of AMG 176, a novel, potent and selective Mcl-1 inhibitor with robust anti-tumor activity in Mcl-1 dependent cancer models
    Caenepeel, Sean R.
    Belmontes, Brian
    Sun, Jan
    Coxon, Angela
    Moody, Gordon
    Hughes, Paul E.
    CANCER RESEARCH, 2017, 77
  • [23] Selective FGFR4 inhibitor Irpagratinib (ABSK011) exhibits broad synergistic and combinatory anti-tumor effects with other therapeutic agents in preclinical HCC models
    Zhang, Nannan
    Shen, Bin
    He, Zhidong
    Dai, Cheng
    Wang, Jie
    Zhang, Jie
    Liu, Manqi
    Zhang, Yongxian
    Chen, Zhui
    CANCER RESEARCH, 2024, 84 (06)
  • [24] COH-203, a novel microtubule inhibitor, exhibits potent anti-tumor activity via p53-dependent senescence in hepatocellular carcinoma
    Qi, Huan
    Zuo, Dai-Ying
    Bai, Zhao-Shi
    Xu, Jing-Wen
    Li, Zeng-Qiang
    Shen, Qi-Rong
    Wang, Zhi-Wei
    Zhang, Wei-Ge
    Wu, Ying-Liang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 455 (3-4) : 262 - 268
  • [25] Preclinical evaluation of eFT226, a potent and selective eIF4A inhibitor with anti-tumor activity in FGFR1,2 and HER2 driven cancers
    Thompson, Peggy A.
    Young, Nathan P.
    Gerson-Gurwitz, Adina
    Eam, Boreth
    Goel, Vikas
    Stumpf, Craig R.
    Chen, Joan
    Parker, Gregory S.
    Fish, Sarah
    Barrera, Maria
    Sung, Eric
    Staunton, Jocelyn
    Chiang, Gary G.
    Webster, Kevin R.
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Combination of an ERK1/2 inhibitor (LY3214996) with VEGFR-2 inhibitor enhances anti-tumor activity in KRAS mutant non-small cell lung cancer
    Wu, Wenjuan
    Bhagwat, Shripad V.
    Jones, Bonita D.
    Swearingen, Michelle L.
    Falcon, Beverly L.
    McMillen, William T.
    Joseph, Sajan
    Buchanan, Sean
    Peng, Sheng-Bin
    Reinhard, Christoph
    Tiu, Ramon V.
    CANCER RESEARCH, 2018, 78 (13)
  • [27] EVT-701 is a novel selective and safe mitochondrial complex 1 inhibitor with potent anti-tumor activity in models of solid cancers
    Luna Yolba, Raquel
    Visentin, Virgile
    Herve, Caroline
    Chiche, Johanna
    Ricci, Jean-Ehrland
    Meneyrol, Jerome
    Paillasse, Michael R.
    Alet, Nathalie
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (05):
  • [28] Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo
    Wu, Jianzhang
    Ji, Jiansong
    Weng, Bixia
    Qiu, Peihong
    Kanchana, Karvannan
    Wei, Tao
    Wang, Yi
    Cai, Yuepiao
    Li, Xiaokun
    Liang, Guang
    ONCOTARGET, 2014, 5 (12) : 4543 - 4553
  • [29] A Novel Benzocoumarin-Stilbene Hybrid as a DNA ligase I inhibitor with in vitro and in vivo anti-tumor activity in breast cancer models
    Mohd. Kamil Hussain
    Deependra Kumar Singh
    Akhilesh Singh
    Mohd. Asad
    Mohd. Imran Ansari
    Mohammad Shameem
    Shagun Krishna
    Guru R. Valicherla
    Vishal Makadia
    Sanjeev Meena
    Amit Laxmikant Deshmukh
    Jiaur R. Gayen
    Mohammad Imran Siddiqi
    Dipak Datta
    Kanchan Hajela
    Dibyendu Banerjee
    Scientific Reports, 7
  • [30] A Novel Benzocoumarin-Stilbene Hybrid as a DNA ligase I inhibitor with in vitro and in vivo anti-tumor activity in breast cancer models
    Hussain, Mohd Kamil
    Singh, Deependra Kumar
    Singh, Akhilesh
    Asad, Mohd
    Ansari, Mohd Imran
    Shameem, Mohammad
    Krishna, Shagun
    Valicherla, Guru R.
    Makadia, Vishal
    Meena, Sanjeev
    Deshmukh, Amit Laxmikant
    Gayen, Jiaur R.
    Siddiqi, Mohammad Imran
    Datta, Dipak
    Hajela, Kanchan
    Banerjee, Dibyendu
    SCIENTIFIC REPORTS, 2017, 7
12345